SlideShare a Scribd company logo
Futility In Liver
Transplantation
Dr. Abhishek Yadav

Senior consultant GI and Liver Transplantation 

VPS Lakeshore Hospital Kochi
Real life Scenario
• 18 year female patient with Acute liver failure 

• Referred to us on day 4, worsening mentation- intubated at presentation

• Lactate- 10 , on noradrenaline

• Family initially reluctant for transplantation

• Day 6- Ventilated, hemodynamicaly stable ( 2 inotropes), no sepsis, renal shut down—>requiring CRRT

• Family now wants to proceed with a transplantation
Is there a reasonable chance of survival with
transplantation
OR
Will the transplantation be Futile?
Medical Futility
“ Medicine is powerless for
those who are overmastered
by their disease”
Futility in Liver transplantation
Definitions
• Rana et al 2008- Post transplant mortality>wait list
mortality

• Lao et al 2010- One year mortality

• Petrowsky et al 2014- 90 day or in-hospital mortality

• Asrani et al 2015- >50% at 5 years
General definitions of
Futility
• Physiological futility- Transplant very early/very sick
patients 

• Imminent disease futility- Failure of life support pre
transplant

• Lethal condition futility- Advanced HCC

• Qualitative futility- Failure to thrive/ brain injury in ALF
Ethics of Futility
• Related to allocation of scarce
resources 

• Is it relevant to
LDLT?
Equity vs Efficiency
Equity vs Efficiency
Equity

Sickest first policy

MELD

MELD NA

PELD

Share 35
Patient gets preference over “nameless faces”
Equity vs Efficiency
Efficiency 

• Organs allocated where they can be utilised efficiently

• Kidney allocation model/exclude high risk transplants 

• Single patient benefit OR greatest benefit to aggregate of
patients 

• Medical and ethical challenge
Medical acuity
• Level of severity of an illness

• Initially conceptualised for allocation of nursing resources
Pre-transplant Acuity
Liver related + Liver unrelated illness
Organ involvement in Liver
disease
Framework to determine
futility
Transplant responsive
conditions 

Encephalopathy 

Ascites

Coagulopathy
Scoring
systems
Transplant Non Responsive
conditions
CAD

COPD

Sarcopenia

Older age
Framework to determine
futility
• a
Most patients belong
here
Scenarios
• Transplantation for high MELD patients - MELD>40

• Transplantation in ACLF

• Transplantation in ALF

• Age and Co-morbidities

• Frailty and Sarcopenia 

• Pulmonary conditions - PPH, HPS
Transplantation for MELD
>40
• MELD score was introduced in 2002 as an allocation
score 

• Not an outcomes assessment tool

• Most evidence suggests worse outcomes and higher
resource utilisation

• Is transplanting these patients worth it?

• Which subset predicts futility?
Analysis of UNOS data over 10 years
8% transplants for patients with MELD>40
• 1 year graft and patient survival 77 and 66% respectively 

• Significantly lower than lower MELD cohorts

• Futile transplants ( 3 month mortality) were 2 times more
than MELD<30 cohort 

• Futility predictors- Age >60, obesity, pre transplant
ventilation, multiple co-morbidities
Pre transplant septic shock

High cardiac risk score

Charlson co morbidity index>6
Predictors of higher
Futility
10 times more
spending on patients
with MELD score >30
Acute on Chronic liver
failure
Dynamic category of liver failure associated with other organ
involvement
Acute on Chronic Liver
Failure
• Evolution of illness is dynamic

• Clinical course between day 3-7 is crucial 

• Therefore these patients have a narrow window of
opportunity for transplantation

• Results of transplantation are dependent on other organ
systems involvement
4 or more organ failures
ACLF 3 on day 3-7
High chances
of futile transplant
Unfortunately 75% fall in this sub group
• French Multi centre study

• Transplantation for ACLF -3

• Results similar to ACLF1,2

• Higher post transplant complications 

• Better post transplant care/ centre experience

• Shorter pre transplant ICU stay—> early referral!
Acute on Chronic Liver
Failure
• Early listing for transplantation

• De- listing should be dynamic 

• Ongoing GI bleed, sepsis control <24 hours definite
contra indications

• Subjective parameters cannot be neglected

• Centre experience plays a major role in outcomes
Acute Liver Failure
• Accounts for 10-15% of transplants world wide

• Results of transplantation worse than other indications

• Well defined listing criteria King’s college criteria etc

• Few guidelines to guide when not to transplant other than
irreversible brain injury
3 risk factors- 30% 90 day mortality
4 risk factors- 50% 90 day mortality
Inotropes

RRT

Blood group non-A

Non Paracetamol etiology 

Higher death
on waiting list
Inotropes
Age>45
Use of high risk grafts
Predictors of
Futility
Age and Co morbidities
• Increasingly geriatric population being listed for
transplantation

• 5% in the UNOS database >70 years

• Marginally lower survival when age adjusted for co
morbidities

• No defined age cut off 

• Most centres would not list above 75 years
Co Morbidities and Futility
• Few studies have evaluated the effects of co morbidities
on results of transplantation

• Though individual diseases might not affect the outcomes

• A combination of co morbidities might be ominous —>
the concept of multiplication of risk factors
• Charlson co morbidity index-
score of 9 co-morbidities 

• 5 diseases were significantly
associated with outcomes
Physical Frailty and
Outcomes
• Frailty originates from geriatric practise

• Biological syndrome leading to increased vulnerability 

• Co-morbidity is a risk factor for frailty

• Fried frailty index, six minute walk test, frailty index—>
scores for frailty

• Frail patients have a low reserve to tolerate complications
—> Sepsis, delayed graft function etc.
Sarcopenia and outcomes
• Effect of liver disease on sarcopenia is well described

• Gut- Liver axis and Liver-muscle axis are gaining interest 

• Sarcopenia is a good morphological correlate to frailty

• Hand grip strength, stair climb power test, six minute walk
distance, CT scan, bio electric impedance - Measures of
sarcopenia

• BMI, skin fold thickness unreliable because of fluid
retention
• TPA (total psoas area)- area of the psoas
muscles measured at L3-4 level

• Psoas muscle area has been shown to
have a direct relationship with sarcopenia
and poor outcomes after transplantation
Pulmonary complications
• Hepato- pulmonary syndrome
• 15-30% prevalence 

• PaO2 <70, intra pulmonary shunts 

• No correlation with severity of liver diseases

• No evidence of poor post transplant outcomes
Pulmonary Complications
• Porto pulmonary hypertension
• mPAP>25, PVR >240 dynes/cm, pawp<15mm hg

• Mild-mPAP 25-35; Moderate-mPAP 35-45; Severe-
mPAP >45

• Reversibility with transplantation unpredictable

• High peri operative mortality 

• High futility when unresponsive to medical management
Scoring systems to predict
futility
• Numerous complex scores
have been proposed to predict
outcomes 

• Balance of Risk ( BAR)
score
• SOFT score- survival
outcomes after liver
transplantation 

• p-SOFT score 

• None of these have been
validate
Too Sick to Transplant
• >4 organ failure (liver, kidney, lungs, circulation, brain)

• Brain oedema and herniation

• Circulatory failure>vasopressors with limited responsiveness

• Severe PPH

• Maximal ventilatory support/ECMO

• Infection- bacteraemia/ fungaemia, septic shock, active SBP
Conclusions
• No reliable and validated de-listing criteria exist

• Very small window of opportunity to transplant in ALF and
ACLF

• Transplant non-responsive conditions should weigh heavy in
decision making

• High MELD patients entail higher resources and
complications

• Extra hepatic system involvement determines success in
transplantation for ACLF
Conclusions
• Combination of co morbidities could determine futility

• Frailty and Sarcopenia are often neglected in decision making

• There will always be an element of subjectivity
• Criteria shift with individual and centre
experience

More Related Content

What's hot

Transplantation 2020 - the big picture
Transplantation 2020 - the big pictureTransplantation 2020 - the big picture
Transplantation 2020 - the big picture
Maarten Naesens
 
ESPEN GUIDELINES NUTRITION SURGERY.pptx
ESPEN GUIDELINES NUTRITION SURGERY.pptxESPEN GUIDELINES NUTRITION SURGERY.pptx
ESPEN GUIDELINES NUTRITION SURGERY.pptx
masoom parwez
 
Gastrointestinal lymphoma
Gastrointestinal lymphomaGastrointestinal lymphoma
Gastrointestinal lymphoma
Varun Babu
 
Liver transplantation - workshop
Liver transplantation   - workshopLiver transplantation   - workshop
Liver transplantation - workshop
hr77
 
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)
Pratap Tiwari
 
Meld scoring
Meld scoringMeld scoring
Meld scoring
Dr. Rohit Saini
 
Liver transplant
Liver transplantLiver transplant
Liver transplant
Dhileeban Maharajan
 
Contrast induced nephropathy
Contrast induced nephropathyContrast induced nephropathy
Contrast induced nephropathy
HoangPhung15
 
Management of acute variceal bleeding
Management of acute variceal bleedingManagement of acute variceal bleeding
Management of acute variceal bleeding
Hidayat Shariff
 
Primary Biliary Cholangitis
Primary Biliary CholangitisPrimary Biliary Cholangitis
Primary Biliary Cholangitis
Pratap Tiwari
 
Liver transplantation
Liver transplantationLiver transplantation
Liver transplantation
Imran Qaisar
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure
Suresh Gorka
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
Vijay Yadav
 
Renal replacement therapy
Renal replacement therapy Renal replacement therapy
Renal replacement therapy
AmiraMuhammad4
 
An update on cancer after kidney transplantation
An update on cancer after kidney transplantationAn update on cancer after kidney transplantation
An update on cancer after kidney transplantation
scienthiasanjeevani1
 
Neuroendocrine tumors (Gastroduodenal)
Neuroendocrine tumors (Gastroduodenal)Neuroendocrine tumors (Gastroduodenal)
Neuroendocrine tumors (Gastroduodenal)
jrajbomman
 
Non traumatic hematuria - Workup and Management
Non traumatic hematuria - Workup and ManagementNon traumatic hematuria - Workup and Management
Non traumatic hematuria - Workup and Management
Dr Santosh Kumaraswamy
 
Kidney in sickle cell disease
Kidney in sickle cell diseaseKidney in sickle cell disease
Kidney in sickle cell diseaseVishal Ramteke
 
Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)
Usama Ragab
 
Approach to Hematuria
Approach to HematuriaApproach to Hematuria
Approach to Hematuria
Ravi Kumar
 

What's hot (20)

Transplantation 2020 - the big picture
Transplantation 2020 - the big pictureTransplantation 2020 - the big picture
Transplantation 2020 - the big picture
 
ESPEN GUIDELINES NUTRITION SURGERY.pptx
ESPEN GUIDELINES NUTRITION SURGERY.pptxESPEN GUIDELINES NUTRITION SURGERY.pptx
ESPEN GUIDELINES NUTRITION SURGERY.pptx
 
Gastrointestinal lymphoma
Gastrointestinal lymphomaGastrointestinal lymphoma
Gastrointestinal lymphoma
 
Liver transplantation - workshop
Liver transplantation   - workshopLiver transplantation   - workshop
Liver transplantation - workshop
 
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)
 
Meld scoring
Meld scoringMeld scoring
Meld scoring
 
Liver transplant
Liver transplantLiver transplant
Liver transplant
 
Contrast induced nephropathy
Contrast induced nephropathyContrast induced nephropathy
Contrast induced nephropathy
 
Management of acute variceal bleeding
Management of acute variceal bleedingManagement of acute variceal bleeding
Management of acute variceal bleeding
 
Primary Biliary Cholangitis
Primary Biliary CholangitisPrimary Biliary Cholangitis
Primary Biliary Cholangitis
 
Liver transplantation
Liver transplantationLiver transplantation
Liver transplantation
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Renal replacement therapy
Renal replacement therapy Renal replacement therapy
Renal replacement therapy
 
An update on cancer after kidney transplantation
An update on cancer after kidney transplantationAn update on cancer after kidney transplantation
An update on cancer after kidney transplantation
 
Neuroendocrine tumors (Gastroduodenal)
Neuroendocrine tumors (Gastroduodenal)Neuroendocrine tumors (Gastroduodenal)
Neuroendocrine tumors (Gastroduodenal)
 
Non traumatic hematuria - Workup and Management
Non traumatic hematuria - Workup and ManagementNon traumatic hematuria - Workup and Management
Non traumatic hematuria - Workup and Management
 
Kidney in sickle cell disease
Kidney in sickle cell diseaseKidney in sickle cell disease
Kidney in sickle cell disease
 
Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis (PSC)
 
Approach to Hematuria
Approach to HematuriaApproach to Hematuria
Approach to Hematuria
 

Similar to Futility in liver transplantation

Overview of liver transplantation
Overview of liver transplantationOverview of liver transplantation
Overview of liver transplantation
hr77
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplant
Dr. Rohit Saini
 
Dr lvk liver transplpantation l.venkatakrishan
Dr lvk   liver transplpantation  l.venkatakrishanDr lvk   liver transplpantation  l.venkatakrishan
Dr lvk liver transplpantation l.venkatakrishan
rrsolution
 
5 lacerda liver disease
5 lacerda liver disease5 lacerda liver disease
5 lacerda liver diseaseangel4567
 
RRT
RRTRRT
Ocular Melanoma and Liver Metastases
Ocular Melanoma and Liver MetastasesOcular Melanoma and Liver Metastases
Ocular Melanoma and Liver Metastases
Melanoma Research Foundation
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
FarragBahbah
 
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptxHEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
Mkindi Mkindi
 
Perspectives in Peritoneal Dialysis
Perspectives in Peritoneal DialysisPerspectives in Peritoneal Dialysis
Perspectives in Peritoneal Dialysis
Richard McCrory
 
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
The ALS Association
 
5_6125448697896502769.pptx
5_6125448697896502769.pptx5_6125448697896502769.pptx
5_6125448697896502769.pptx
DeepshikhaKar1
 
Indications of peritoneal dialysis
Indications of peritoneal dialysisIndications of peritoneal dialysis
Indications of peritoneal dialysis
Muhammad Mohsin Riaz
 
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptx
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptxKidney-Transplantation-PowerPoint-Presentation-compressed.pptx
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptx
Alshifa healthcare services
 
Revolutionizing Renal Care With Predictive Analytics for CKD
Revolutionizing Renal Care With Predictive Analytics for CKDRevolutionizing Renal Care With Predictive Analytics for CKD
Revolutionizing Renal Care With Predictive Analytics for CKD
Viewics
 
SBRT IN LIVER TUMOURS- DR UPASNA.pptx
SBRT IN LIVER TUMOURS- DR UPASNA.pptxSBRT IN LIVER TUMOURS- DR UPASNA.pptx
SBRT IN LIVER TUMOURS- DR UPASNA.pptx
Upasna Saxena
 
Liver transplantation current status, controversies and myths
Liver transplantation current status, controversies and mythsLiver transplantation current status, controversies and myths
Liver transplantation current status, controversies and myths
Abhishek Yadav
 
Acute Medicine Skills Part One
Acute Medicine Skills Part OneAcute Medicine Skills Part One
Acute Medicine Skills Part One
RecoveryPackage
 
Lines of ttt of p ca
Lines of ttt of p caLines of ttt of p ca
Lines of ttt of p ca
Ahmed Eliwa
 
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTINGKIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
Dr Mayank Mohan Agarwal
 
THYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptxTHYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptx
masoom parwez
 

Similar to Futility in liver transplantation (20)

Overview of liver transplantation
Overview of liver transplantationOverview of liver transplantation
Overview of liver transplantation
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplant
 
Dr lvk liver transplpantation l.venkatakrishan
Dr lvk   liver transplpantation  l.venkatakrishanDr lvk   liver transplpantation  l.venkatakrishan
Dr lvk liver transplpantation l.venkatakrishan
 
5 lacerda liver disease
5 lacerda liver disease5 lacerda liver disease
5 lacerda liver disease
 
RRT
RRTRRT
RRT
 
Ocular Melanoma and Liver Metastases
Ocular Melanoma and Liver MetastasesOcular Melanoma and Liver Metastases
Ocular Melanoma and Liver Metastases
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
 
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptxHEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
HEPATOCELLULAR AND GALL BLADDER CARCINOMA.pptx
 
Perspectives in Peritoneal Dialysis
Perspectives in Peritoneal DialysisPerspectives in Peritoneal Dialysis
Perspectives in Peritoneal Dialysis
 
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
Presentation 229 b pamela kittrell safety of peg tube insertion in patients w...
 
5_6125448697896502769.pptx
5_6125448697896502769.pptx5_6125448697896502769.pptx
5_6125448697896502769.pptx
 
Indications of peritoneal dialysis
Indications of peritoneal dialysisIndications of peritoneal dialysis
Indications of peritoneal dialysis
 
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptx
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptxKidney-Transplantation-PowerPoint-Presentation-compressed.pptx
Kidney-Transplantation-PowerPoint-Presentation-compressed.pptx
 
Revolutionizing Renal Care With Predictive Analytics for CKD
Revolutionizing Renal Care With Predictive Analytics for CKDRevolutionizing Renal Care With Predictive Analytics for CKD
Revolutionizing Renal Care With Predictive Analytics for CKD
 
SBRT IN LIVER TUMOURS- DR UPASNA.pptx
SBRT IN LIVER TUMOURS- DR UPASNA.pptxSBRT IN LIVER TUMOURS- DR UPASNA.pptx
SBRT IN LIVER TUMOURS- DR UPASNA.pptx
 
Liver transplantation current status, controversies and myths
Liver transplantation current status, controversies and mythsLiver transplantation current status, controversies and myths
Liver transplantation current status, controversies and myths
 
Acute Medicine Skills Part One
Acute Medicine Skills Part OneAcute Medicine Skills Part One
Acute Medicine Skills Part One
 
Lines of ttt of p ca
Lines of ttt of p caLines of ttt of p ca
Lines of ttt of p ca
 
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTINGKIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
KIDNEY TRANSPLANTATION PREPARATION AND CONSENTING
 
THYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptxTHYROID MALIGNANCIES.pptx
THYROID MALIGNANCIES.pptx
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

Futility in liver transplantation

  • 1. Futility In Liver Transplantation Dr. Abhishek Yadav Senior consultant GI and Liver Transplantation VPS Lakeshore Hospital Kochi
  • 2. Real life Scenario • 18 year female patient with Acute liver failure • Referred to us on day 4, worsening mentation- intubated at presentation • Lactate- 10 , on noradrenaline • Family initially reluctant for transplantation • Day 6- Ventilated, hemodynamicaly stable ( 2 inotropes), no sepsis, renal shut down—>requiring CRRT • Family now wants to proceed with a transplantation Is there a reasonable chance of survival with transplantation OR Will the transplantation be Futile?
  • 3. Medical Futility “ Medicine is powerless for those who are overmastered by their disease”
  • 4. Futility in Liver transplantation Definitions • Rana et al 2008- Post transplant mortality>wait list mortality • Lao et al 2010- One year mortality • Petrowsky et al 2014- 90 day or in-hospital mortality • Asrani et al 2015- >50% at 5 years
  • 5. General definitions of Futility • Physiological futility- Transplant very early/very sick patients • Imminent disease futility- Failure of life support pre transplant • Lethal condition futility- Advanced HCC • Qualitative futility- Failure to thrive/ brain injury in ALF
  • 6. Ethics of Futility • Related to allocation of scarce resources • Is it relevant to LDLT? Equity vs Efficiency
  • 7. Equity vs Efficiency Equity Sickest first policy MELD MELD NA PELD Share 35 Patient gets preference over “nameless faces”
  • 8. Equity vs Efficiency Efficiency • Organs allocated where they can be utilised efficiently • Kidney allocation model/exclude high risk transplants • Single patient benefit OR greatest benefit to aggregate of patients • Medical and ethical challenge
  • 9. Medical acuity • Level of severity of an illness • Initially conceptualised for allocation of nursing resources
  • 10. Pre-transplant Acuity Liver related + Liver unrelated illness
  • 11. Organ involvement in Liver disease
  • 12. Framework to determine futility Transplant responsive conditions Encephalopathy Ascites Coagulopathy Scoring systems Transplant Non Responsive conditions CAD COPD Sarcopenia Older age
  • 13. Framework to determine futility • a Most patients belong here
  • 14. Scenarios • Transplantation for high MELD patients - MELD>40 • Transplantation in ACLF • Transplantation in ALF • Age and Co-morbidities • Frailty and Sarcopenia • Pulmonary conditions - PPH, HPS
  • 15. Transplantation for MELD >40 • MELD score was introduced in 2002 as an allocation score • Not an outcomes assessment tool • Most evidence suggests worse outcomes and higher resource utilisation • Is transplanting these patients worth it? • Which subset predicts futility?
  • 16. Analysis of UNOS data over 10 years 8% transplants for patients with MELD>40
  • 17. • 1 year graft and patient survival 77 and 66% respectively • Significantly lower than lower MELD cohorts • Futile transplants ( 3 month mortality) were 2 times more than MELD<30 cohort • Futility predictors- Age >60, obesity, pre transplant ventilation, multiple co-morbidities
  • 18. Pre transplant septic shock High cardiac risk score Charlson co morbidity index>6 Predictors of higher Futility
  • 19. 10 times more spending on patients with MELD score >30
  • 20. Acute on Chronic liver failure Dynamic category of liver failure associated with other organ involvement
  • 21. Acute on Chronic Liver Failure • Evolution of illness is dynamic • Clinical course between day 3-7 is crucial • Therefore these patients have a narrow window of opportunity for transplantation • Results of transplantation are dependent on other organ systems involvement
  • 22. 4 or more organ failures ACLF 3 on day 3-7 High chances of futile transplant Unfortunately 75% fall in this sub group
  • 23. • French Multi centre study • Transplantation for ACLF -3 • Results similar to ACLF1,2 • Higher post transplant complications • Better post transplant care/ centre experience • Shorter pre transplant ICU stay—> early referral!
  • 24. Acute on Chronic Liver Failure • Early listing for transplantation • De- listing should be dynamic • Ongoing GI bleed, sepsis control <24 hours definite contra indications • Subjective parameters cannot be neglected • Centre experience plays a major role in outcomes
  • 25. Acute Liver Failure • Accounts for 10-15% of transplants world wide • Results of transplantation worse than other indications • Well defined listing criteria King’s college criteria etc • Few guidelines to guide when not to transplant other than irreversible brain injury
  • 26. 3 risk factors- 30% 90 day mortality 4 risk factors- 50% 90 day mortality
  • 27. Inotropes RRT Blood group non-A Non Paracetamol etiology Higher death on waiting list Inotropes Age>45 Use of high risk grafts Predictors of Futility
  • 28. Age and Co morbidities • Increasingly geriatric population being listed for transplantation • 5% in the UNOS database >70 years • Marginally lower survival when age adjusted for co morbidities • No defined age cut off • Most centres would not list above 75 years
  • 29. Co Morbidities and Futility • Few studies have evaluated the effects of co morbidities on results of transplantation • Though individual diseases might not affect the outcomes • A combination of co morbidities might be ominous —> the concept of multiplication of risk factors
  • 30. • Charlson co morbidity index- score of 9 co-morbidities • 5 diseases were significantly associated with outcomes
  • 31. Physical Frailty and Outcomes • Frailty originates from geriatric practise • Biological syndrome leading to increased vulnerability • Co-morbidity is a risk factor for frailty • Fried frailty index, six minute walk test, frailty index—> scores for frailty • Frail patients have a low reserve to tolerate complications —> Sepsis, delayed graft function etc.
  • 32. Sarcopenia and outcomes • Effect of liver disease on sarcopenia is well described • Gut- Liver axis and Liver-muscle axis are gaining interest • Sarcopenia is a good morphological correlate to frailty • Hand grip strength, stair climb power test, six minute walk distance, CT scan, bio electric impedance - Measures of sarcopenia • BMI, skin fold thickness unreliable because of fluid retention
  • 33. • TPA (total psoas area)- area of the psoas muscles measured at L3-4 level • Psoas muscle area has been shown to have a direct relationship with sarcopenia and poor outcomes after transplantation
  • 34. Pulmonary complications • Hepato- pulmonary syndrome • 15-30% prevalence • PaO2 <70, intra pulmonary shunts • No correlation with severity of liver diseases • No evidence of poor post transplant outcomes
  • 35. Pulmonary Complications • Porto pulmonary hypertension • mPAP>25, PVR >240 dynes/cm, pawp<15mm hg • Mild-mPAP 25-35; Moderate-mPAP 35-45; Severe- mPAP >45 • Reversibility with transplantation unpredictable • High peri operative mortality • High futility when unresponsive to medical management
  • 36. Scoring systems to predict futility • Numerous complex scores have been proposed to predict outcomes • Balance of Risk ( BAR) score
  • 37. • SOFT score- survival outcomes after liver transplantation • p-SOFT score • None of these have been validate
  • 38. Too Sick to Transplant • >4 organ failure (liver, kidney, lungs, circulation, brain) • Brain oedema and herniation • Circulatory failure>vasopressors with limited responsiveness • Severe PPH • Maximal ventilatory support/ECMO • Infection- bacteraemia/ fungaemia, septic shock, active SBP
  • 39. Conclusions • No reliable and validated de-listing criteria exist • Very small window of opportunity to transplant in ALF and ACLF • Transplant non-responsive conditions should weigh heavy in decision making • High MELD patients entail higher resources and complications • Extra hepatic system involvement determines success in transplantation for ACLF
  • 40. Conclusions • Combination of co morbidities could determine futility • Frailty and Sarcopenia are often neglected in decision making • There will always be an element of subjectivity • Criteria shift with individual and centre experience